Top Markets
Coin of the day
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
Rangering i aksjer #39866
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Aksjekurs
$0.83601504
Markedsverdi
$315.65K
Endring (1 dag)
3.26%
Endring (1 år)
-2.68%
Land
GB
Handel Arecor Therapeutics plc (AREC)

Kategori

Utbytteavkastning for Arecor Therapeutics plc (AREC)
Arecor Therapeutics plc (aksjesymbol: AREC) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Arecor Therapeutics plc (AREC) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter